日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Ralstonia solanacearum Elongation factor G 1 (fusA), partial CSB-YP841401RAR
CSB-EP841401RAR
CSB-BP841401RAR
CSB-MP841401RAR
CSB-EP841401RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum 30S ribosomal protein S3 (rpsC) CSB-YP841402RAR
CSB-EP841402RAR
CSB-BP841402RAR
CSB-MP841402RAR
CSB-EP841402RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum 30S ribosomal protein S14 (rpsN) CSB-YP841403RAR
CSB-EP841403RAR
CSB-BP841403RAR
CSB-MP841403RAR
CSB-EP841403RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum DNA-directed RNA polymerase subunit alpha (rpoA) CSB-YP841404RAR
CSB-EP841404RAR
CSB-BP841404RAR
CSB-MP841404RAR
CSB-EP841404RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Protein CyaY (cyaY) CSB-YP841405RAR
CSB-EP841405RAR
CSB-BP841405RAR
CSB-MP841405RAR
CSB-EP841405RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Imidazole glycerol phosphate synthase subunit HisH (hisH) CSB-YP841406RAR
CSB-EP841406RAR
CSB-BP841406RAR
CSB-MP841406RAR
CSB-EP841406RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Large-conductance mechanosensitive channel (mscL), partial CSB-YP841407RAR1
CSB-EP841407RAR1
CSB-BP841407RAR1
CSB-MP841407RAR1
CSB-EP841407RAR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Protein MraZ (mraZ) CSB-YP841408RAR
CSB-EP841408RAR
CSB-BP841408RAR
CSB-MP841408RAR
CSB-EP841408RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum UDP-N-acetylmuramate--L-alanine ligase (murC) CSB-YP841409RAR
CSB-EP841409RAR
CSB-BP841409RAR
CSB-MP841409RAR
CSB-EP841409RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Glutamate 5-kinase (proB) CSB-YP841410RAR
CSB-EP841410RAR
CSB-BP841410RAR
CSB-MP841410RAR
CSB-EP841410RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Dihydrodipicolinate reductase (dapB) CSB-YP841411RAR
CSB-EP841411RAR
CSB-BP841411RAR
CSB-MP841411RAR
CSB-EP841411RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Probable inorganic polyphosphate/ATP-NAD kinase (ppnK) CSB-YP841412RAR
CSB-EP841412RAR
CSB-BP841412RAR
CSB-MP841412RAR
CSB-EP841412RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum 3-methyl-2-oxobutanoate hydroxymethyltransferase (panB) CSB-YP841413RAR
CSB-EP841413RAR
CSB-BP841413RAR
CSB-MP841413RAR
CSB-EP841413RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum UPF0234 protein RSc2549 (RSc2549) CSB-YP841414RAR
CSB-EP841414RAR
CSB-BP841414RAR
CSB-MP841414RAR
CSB-EP841414RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Quinolinate synthase A (nadA) CSB-YP841415RAR
CSB-EP841415RAR
CSB-BP841415RAR
CSB-MP841415RAR
CSB-EP841415RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Acetylornithine aminotransferase (argD) CSB-YP841416RAR
CSB-EP841416RAR
CSB-BP841416RAR
CSB-MP841416RAR
CSB-EP841416RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Cobyric acid synthase (cobQ) CSB-YP841417RAR
CSB-EP841417RAR
CSB-BP841417RAR
CSB-MP841417RAR
CSB-EP841417RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Inorganic pyrophosphatase (ppa) CSB-YP841418RAR
CSB-EP841418RAR
CSB-BP841418RAR
CSB-MP841418RAR
CSB-EP841418RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Exodeoxyribonuclease 7 small subunit (xseB) CSB-YP841419RAR
CSB-EP841419RAR
CSB-BP841419RAR
CSB-MP841419RAR
CSB-EP841419RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Uracil phosphoribosyltransferase (upp) CSB-YP841420RAR
CSB-EP841420RAR
CSB-BP841420RAR
CSB-MP841420RAR
CSB-EP841420RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×